Can I read Frailty, Sarcopenia and Diabetic Kidney Disease: Where Do We Stand? on EtoBox?

Frailty, Sarcopenia and Diabetic Kidney Disease: Where Do We Stand? by Nikolaos D. Karakousis; Smaragda Biliou; Elisavet E. Pyrgioti; Petros N. Georgakopoulos; Vassilios Liakopoulos; Nikolaos Papanas is a Medicine article available to read on EtoBox.

What is Frailty, Sarcopenia and Diabetic Kidney Disease: Where Do We Stand? about?

The aim of this narrative non-systematic review was to investigate the potential interplay among frailty syndrome, sarcopenia and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) patients. Data derived from a limited number of studies underline that DKD is a significant risk factor for frailty. On the other hand, frailty syndrome poses a higher risk for end-stage renal disease (ESRD) in subjects with DKD. In addition, frailty seems to affect the cognitive function and social life of DKD individuals, whilst as DKD deteriorates, there is a higher prevalence of sarcopenia which is a fundamental frailty factor. As a result, it is shown that a bidirectional relation is established between these entities, as diabetes mellitus (DM) affects the components of frailty and sarcopenia and vice versa. This vicious cycle is created through multiple pathophysiologic mechanisms, including the anabolic role of insulin, low-grade inflammation, cytokines and endothelial function, prompting further investigation in this area. Specific nutritional and exercise interventions are imperative to be established in order to ameliorate potential adverse outcomes, concerning these entities.

Who reads Frailty, Sarcopenia and Diabetic Kidney Disease: Where Do We Stand??

Author

Nikolaos D. Karakousis; Smaragda Biliou; Elisavet E. Pyrgioti; Petros N. Georgakopoulos; Vassilios Liakopoulos; Nikolaos Papanas

Publisher

Springer Science and Business Media LLC

Published

2022

Language

EN

Field

Medicine (Health Sciences)